BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 209043)

  • 21. Phosphorylation of farnesol in rat liver microsomes: properties of farnesol kinase and farnesyl phosphate kinase.
    Bentinger M; Grünler J; Peterson E; Swiezewska E; Dallner G
    Arch Biochem Biophys; 1998 May; 353(2):191-8. PubMed ID: 9606952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation of 12-cis-dehydrosqualene catalyzed by squalene synthetase.
    Nishino T; Katsuki H
    Methods Enzymol; 1985; 110():373-5. PubMed ID: 3894880
    [No Abstract]   [Full Text] [Related]  

  • 23. Purification and properties of sterol carrier protein1.
    Srikantaiah MV; Hansbury E; Loughran ED; Scallen TJ
    J Biol Chem; 1976 Sep; 251(18):5496-504. PubMed ID: 965373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymic conversion of farnesyl pyrophosphate to squalene.
    Krishna G; Whitlock HW; Feldbruegge DH; Porter JW
    Arch Biochem Biophys; 1966 Apr; 114(1):200-15. PubMed ID: 4380977
    [No Abstract]   [Full Text] [Related]  

  • 25. The conversion of farnesyl pyrophosphate to squalene by soluble extracts of microsomes.
    ANDERSON DG; RICE MS; PORTER JW
    Biochem Biophys Res Commun; 1960 Dec; 3():591-5. PubMed ID: 13683185
    [No Abstract]   [Full Text] [Related]  

  • 26. Postnatal developmental profile of 3-hydroxy-3-methylglutaryl-CoA reductase, squalene synthetase and cholesterol 7 alpha-hydroxylase activities in the liver of domestic swine.
    Kwekkeboom J; Kempen HJ; van Voorthuizen EM; Griffioen M; Cohen LH
    Biochim Biophys Acta; 1990 Jan; 1042(1):146-9. PubMed ID: 2297519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An enzyme-bound intermediate in the conversion of farnesyl pyrophosphate to squalene.
    Krishna G; Feldbruegge DH; Porter JW
    Biochem Biophys Res Commun; 1964; 14():363-9. PubMed ID: 4284347
    [No Abstract]   [Full Text] [Related]  

  • 28. Intermembrane transfer of 5 alpha-cholest-7-en-3 beta-ol. Facilitation by supernatant protein (SCP).
    Ishibashi T; Bloch K
    J Biol Chem; 1981 Dec; 256(24):12962-7. PubMed ID: 7309744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of presqualene pyrophosphate by liver microsomes.
    Rilling HC
    J Lipid Res; 1970 Sep; 11(5):480-5. PubMed ID: 4322765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for carrier proteins in bile acid synthesis. The effect of squalene and sterol carrier protein and albumin on the activity of 12alpha-hydroxylase.
    Grabowski GA; McCoy KE; Williams GC; Dempsey ME; Hanson RF
    Biochim Biophys Acta; 1976 Sep; 441(3):380-90. PubMed ID: 974090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent changes in rat liver prenyltransferases.
    Thelin A; Runquist M; Ericsson J; Swiezewska E; Dallner G
    Mech Ageing Dev; 1994 Oct; 76(2-3):165-76. PubMed ID: 7885063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoprenoid (phosphinylmethyl)phosphonates as inhibitors of squalene synthetase.
    Biller SA; Forster C; Gordon EM; Harrity T; Scott WA; Ciosek CP
    J Med Chem; 1988 Oct; 31(10):1869-71. PubMed ID: 3172121
    [No Abstract]   [Full Text] [Related]  

  • 33. Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents.
    Cohen LH; Valentijn AR; Roodenburg L; Van Leeuwen RE; Huisman RH; Lutz RJ; Van der Marel GA; Van Boom JH
    Biochem Pharmacol; 1995 Mar; 49(6):839-45. PubMed ID: 7702642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulations in hepatic branch-point enzymes involved in isoprenoid biosynthesis upon dietary and drug treatments of rats.
    Andersson M; Ericsson J; Appelkvist EL; Schedin S; Chojnacki T; Dallner G
    Biochim Biophys Acta; 1994 Aug; 1214(1):79-87. PubMed ID: 8068731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of squalene synthetase and squalene epoxidase activities in Saccharomyces cerevisiae.
    M'Baya B; Fegueur M; Servouse M; Karst F
    Lipids; 1989 Dec; 24(12):1020-3. PubMed ID: 2693869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Squalene synthetase activity in human fibroblasts: regulation via the low density lipoprotein receptor.
    Faust JR; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5018-22. PubMed ID: 228272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereochemistry-dependent inhibition of RAS farnesylation by farnesyl phosphonic acids.
    Hohl RJ; Lewis KA; Cermak DM; Wiemer DF
    Lipids; 1998 Jan; 33(1):39-46. PubMed ID: 9470172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.
    Amin D; Cornell SA; Perrone MH; Bilder GE
    Arzneimittelforschung; 1996 Aug; 46(8):759-62. PubMed ID: 9125274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes.
    Bansal VS; Vaidya S
    Arch Biochem Biophys; 1994 Dec; 315(2):393-9. PubMed ID: 7986083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.